about
Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson's disease.Lipopolysaccharide-Induced Microglia Activation Promotes the Survival of Midbrain Dopaminergic Neurons In Vitro.Postnatal maturation of microglia is associated with alternative activation and activated TGFβ signaling.
P50
description
researcher
@en
name
Björn Spittau
@en
type
label
Björn Spittau
@en
prefLabel
Björn Spittau
@en
P31
P496
0000-0001-5423-0571